Sangamo and Pfizer to Collaborate on Developing Gene Therapies for ALS – ALS News Today
ALS News Today |
Sangamo and Pfizer to Collaborate on Developing Gene Therapies for ALS
ALS News Today Sangamo Therapeutics and Pfizer will work together on gene therapies they hope will overcome mutations that cause ALS and frontotemporal lobar degeneration. Gene therapy works by delivering a healthy copy of a malfunctioning gene to a patient. The … Pfizer and Sangamo Partner on Gene Therapy for Lou Gehrig's Disease Pfizer buys into Sangamo's motor neuron disease gene therapy |
